Skip to main content
. Author manuscript; available in PMC: 2009 Apr 27.
Published in final edited form as: Hypertension. 2008 Feb 7;51(4):1190–1196. doi: 10.1161/HYPERTENSIONAHA.107.105627

Figure 3.

Figure 3

Net release of t-PA activity in response to bradykinin (A), bradykinin plus enalaprilat (B) during placebo (○) and 17β-estradiol treatment (●). Probability values are for repeated measures ANOVA with pairwise comparisons between placebo and 17β-estradiol. Release of t-PA activity versus log bradykinin dose in postmenopausal women in the absence (■) and presence of enalaprilat (□) during placebo (C) and 17β-estradiol treatment (D).